DIANA Biotech (@DianaBiotech) header
DIANA Biotech (@DianaBiotech) profile picture

Diversified Biotech | Built on Research and Development Diagnostics Life Science Monoclonal Antibodies Drug Discovery Based in Czechia

Česká republika
Joined September 2020
Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)Photo by DIANA Biotech (@DianaBiotech)
🔵🟠A Major Step for Early Oncodiagnostics: Liquid Biopsy Concept Successfully Validated! At DIANA Biotechnologies, we have just completed a key phase of our oncodiagnostics project. Our feasibility study has confirmed that the technologies we developed for detecting somatic mutations perform with extraordinary precision even on real patient samples. Why is the project so important? Lead Scientist of oncodiagnostics project, Monika Vilímová, will tell you! 🔵 Why does this matter? ”We focused on pancreatic cancer, one of the most challenging malignancies where early detection is absolutely critical. Our method focuses on detecting 4 key mutations in the KRAS gene, the primary driver of this disease.” 🟠 What is the technological breakthrough? "To capture mutations in blood (liquid biopsy), especially in early stages, extreme sensitivity is required. The amount of tumor DNA in these fluids is minimal, but our assay can: Detect 1 copy of mutant DNA in a sea of 100,000 copies of normal DNA (sensitivity down to 0.001%) and achieve the same parameters in real patient blood samples as in controlled laboratory conditions.” 🔵Is the technology accessible? ”Our technology is accessible to all unlike methods such as NGS or digital PCR, our solution is built on a standard PCR platform. Thanks to our proprietary proteins and sophisticated assay design, we have created a method that is: ✅ Outstanding Sensitivity (outperforming PCR and NGS tests on the market). ✅ Cost-Effective (crucial for large-scale screening programs). ✅ Easy to Implement (can be used by virtually any laboratory). This successful Proof of Concept opens the door to a future where liquid biopsy is a routine tool for earlier and more accurate cancer diagnostics. A huge thank you to the entire team for their fantastic work and to the participating hospitals for their collaboration in sample collection! The project „Feasibility study of PCR method for detection of somatic mutations in liquid biopsy“ was co-funded by the EU through the Operational programme TAC. The project aimed to verify technical and commercial feasibility of development of a PCR method for detection of somatic mutations relevant for application in oncodiagnostics.
1
70
🔵 HIRING: Business Development Manager (Antibodies/Immunoassays) 🟠 Are you a PhD holder who transitioned from the bench to the boardroom? Do you understand the nuances of immunoassays and the art of negotiation? We are hiring a Business Development Manager to join our team in Vestec. This is a critical, senior role for a professional capable of driving growth in a dynamic biotech start-up. The Role: 🔹 Developing market entry strategies & business models. 🔹 Leading technical and commercial negotiations. 🔹 Facilitating academic collaborations & catalogue development. 🔹 Representing the company at international conferences. The Requirements: 🔹 PhD in Life Science or related fields. 🔹 Deep experience in Antibodies or Immunoassays. 🔹 Proven background in BD, Sales, or Product Marketing. 🔹 Ability to draft contracts and lead negotiations. 🔹Fluent english (czech is optional) The Offer: 🔹 Based in Vestec (Prague) 🔹 Competitive Salary 🔹 Partial Remote Work 🔹 5 Weeks Vacation 🔹 High-Growth Environment. If you are ready to take on senior responsibilities in a supportive, innovative biotech company, let’s talk. Get more info and apply here: dianabiotech.com/company/car… #Biotech #SeniorManager #Prague #Vestec #LifeSciences #CommercialStrategy
2
144
🟠 MEDICA - Leading International Trade Fair was great! 🔵 Plenty of meetings, great people and talks! That was @MEDICATradeFair! And we have the opportunity to present: 🟠 Unique Diagnostics of Sepsis: Fast and ultrasensitive. That's how we detect sepsis. 🔵 DB Ultima H RNase Inhibitor: The end of RNA degradation. 🟠 Monoclonal Antibody Development: Too small to detect? Don't worry we will detect it. Our attendance at MEDICA was co-founded by Europeand Union with "Promotion of exports of DIANA Biotechnologies" project. The main aim of the project is to develop new international partnerships, open new markets for our products and promote our unique know-how and R&D potential in the three main areas of our focus: - In vitro diagnostics - Drug discovery (pre-clinical development) - Life Science products
118
🟠 Biotech worlds of Czechia and Switzerland together at Biocev 🔵 It is our pleasure to be part of Czech-Swiss Biotech Innovation Day. Great guests and inspiring talks! 🎤 And one of them will be ours! Do you wonder what are the challenges of building a diversified biotech in Czech republic? Let's hear our co-founder Martin Dienstbier! The day is full of great talks and we are looking forward to hear them. There is just a quick invitation to some of them: 🔴 Matouš Glanc as a @czexpats and his talk about Czech scientist abroad 🔴 Petra Kinzlova as a Prague.bio CEO and biotech hub in the heart of Europe 🔴 Jana De Merlier as a STAR - Research & Innovation Cluster CEO and the challenges of building a innovation ecosystem Looking forward to meet you there! Big thanks to @BIOCEV_science
3
112
🟠 Setting a new standard in RNase inhibition 🔵 RNase inhibition is one of the key things in the RNA world. Ribonucleases are everywhere trying to degrade our RNA. A reliable RNase inhibitor can make the difference between success and failure in sensitive RNA workflows. And we synthetize such an inhibitor! So why is the Ultima H simply the best? 🟠 Full oxidative resistance: Fully active even at 2% H₂O₂. 🔵 Exceptional thermostability: The only protein RNase inhibitor stable above 55 °C. 🔵 Boosts yields and sensitivity! 🟠 Robust and stable: Stays active for months at room temperature. Have some questions? Looking forward to hearing from you!
1
1
102
🇨🇿 | O studiu v zahraničí, biotech sektoru, grantech a hlavně o protilátkách ukforum.cz/rubriky/alumni/96… Podrobný rozhovor s vedoucím našeho vývoje protilátek, Vojtech Vyklicky si můžete přečíst v @ukforumcz. A co všechno se dozvíte? O studiu v Berkeley ➡️ "Mají například separátní parkoviště pro nositele Nobelovy ceny, kteří nemusí platit za stání a před každou budovou je pro ně pět vyhrazených míst. A pak jdete na přednášku a dva tam zrovna sedí." O biotech sektoru ➡️ "V Kalifornii, obzvlášť v Berkeley a celém Silicon Valley, je naprosto běžné, že vedoucí vědeckých týmů mají nějaký vlastní spin-off nebo startup. Ale tady v Česku toho tehdy moc nebylo." O DIANA-Ab technologii ➡️ "Velmi efektivně nacházíme ty nejlepší klony s vysokou afinitou a nízkou nežádoucí reaktivitou u imunizovaných zvířat. Využití je pak trojí: diagnostické, terapeutické a výzkumné."
1
108
Two great events in two weeks! 🔆 It was our great honor to be part of the CK1 conference in @MasarykUni in Brno! We presented the use of DIANA technology to create our inhibitor profiling portfolio. And yes, one of the panels covers CK1s. ➡️ dianabiotech.com/segment/dru… For the next event we need to went even further. The @myADLM conference took place in Chicago and we had a chance to present (no surprises) the DIANA technology again, but in a whole new setup. DIANA-Ab is our platform for very precise and efficient development of new monoclonal antibodies. ➡️dianabiotech.com/segment/mon… It was great to meet all of those great researchers from different fields and we hopefully see you somewhere again!
1
3
148
🚀 Introducing DIANA Inhibitor Profiling — More effective way to screen your compounds. Are the relative potency data not sufficient for your project? Thank to our unique DIANA technology, you will receive robust quantitative potency data right from the start. ✔️Quantitative potency data ✔️ Robust performance in 10% DMSO ✔️ Ultra-low interference via PCR readout ✔️ Results in 7 to 14 days 💡 Customize your inhibitor profiling panel, send your compounds, and start making data-driven decisions fast. 🙋‍♂️ Do you have any questions or are you unsure what panel to use? Schedule a free consultation with one of our DD scientists Lucia Bialesova, Alena Uvizl or Jan Tykvart 👉 Swipe through to see how it works. 🔗 Link in comment below #DrugDiscovery #KinaseProfiling #DIANAtechnology #BioTech
1
1
95
What it takes to launch a biotech startup? Yeah, we might know a thing or two about this 🙌 We are glad to be part of the upcoming workshop of @czexpats at @BIOCEV_science together with other biotech startup founders! Join the workshop and be ready for a thorough discussion about pros and cons, ups and downs of founding biotech startup in Czechia! More info ⏩ czexpats.org/en/udalost/laun…
🚀 Have you ever wondered what it takes to launch a biotech startup – and whether it might be the right path for you? 🚀 Join us for the workshop co-organised with the @IBT_CAS and prague.bio at @BIOCEV_science. 🤩 💡 Four inspiring scientists – startup founders – Petra Szeszula, @MartinDienstbie , David Sedlak and @DanielZucha will share their personal stories, lessons learned, and practical tips for those considering a similar journey. 💡 ℹ More information and registration: czexpats.org/en/udalost/laun…
1
3
376
🔬 Meet Us at the 11th @RSC_BMCS Symposium on Kinase Inhibitor Design! We are excited to be part of the upcoming RSC/SCI Symposium on Kinase Inhibitor Design—a key event in inhibitor profiling! We’ll be showcasing our unique DIANA Technology—a patented solid-phase binding assay platform that combines the specificity of ELISA with the sensitivity of qPCR, enabling precise and interference-free determination of Kd. The technology enable us to create brand new DIANA Panels for inhibitor profiling! 🟦 DIANA Kinase Panel: More than 170 clinically relevant kinases from all kinase groups with true Kd from each measurement! 🟦 DIANA CDK Panel: Selective inhibitor profiling panel exclusively for 24 CDK Kinases! Do you specialize on the CDKs? That's the right choose for you! 🟦 DIANA CA panel: Are you interested in carbonic anhydrases as well? With our CA profiling service, you gain the clarity needed to design safer and more selective compounds! 🔍 Whether you're developing inhibitors for kinases, cyclin-dependent kinases (CDKs), or carbonic anhydrases (CAs), our robust profiling panels offer: Quantitative binding data Minimal interference via qPCR readout Customizable formats and fast turnaround time Scalability: DIANA Assay can be easily translated into HTS format 👉 Let’s talk about how our panels can support your pipeline with our scientists Lucia Bialesova and Jan Tykvart. Find us at booth no. 9 or explore more on dianabiotech.com/segment/dru…
1
120
The @Czexpats awards have been presented! It is a great honour for us to once again award the best Czech scientists abroad! Congratulations to @DrapalJakub, @stanislavfort and @biomonika! The research of all three is worth following! Many thanks to @muni_cz!
🏆 Letošní Ceny @czexpats byly dnes slavnostně předány na @muni_cz! 🫶 Děkujeme za skvělé odpoledne plné vědy napříč obory – od DNA a chromozomu Y, přes podmíněné tresty v českém právním systému, až po potíže umělé inteligence při rozeznávání psa od auta 😁 Díky @biomonika, @DrapalJakub a @stanislavfort za vaše inspirativní přednášky i za podnětnou diskuzi! Jsme rádi, že jste byli dnes s námi – v Brně i online – a děkujeme také @DianaBiotech za spolupráci. Už teď se těšíme na další ročník!🚀
10
270
🎉 The Czexpats Award vol.2 is here! 👩‍🔬👨‍🔬 To connect scientist abroad with those in Czech republic is one of the most important things in our science world. So, we are very glad to be the main sponsor of the @czexpats Award for the best Czech scientist doing their research in foreign countries! This year's ceremony will take place on April 16th at @MasarykUni in Brno, and we’re excited to hear from the three outstanding finalists: 🧬 @biomonika Monika Čechová (genomics & heredity) ⚖️ @DrapalJakub Jakub Drápal (law & criminal justice) 🤖 @stanislavfort Stanislav Fort Fořt (AI safety & machine learning) 💬 Join us in person or online! We’re looking forward to seeing you there and celebrating the success of Czech science across borders! 💙 #CzexpatsAward #DIANABiotechnologies #CzechScience #ScienceAbroad #Innovation #Partnership #AI #Genomics #LawAndJustice #ScientificExcellence
🏆 Slavnostní předávání Ceny @czexpats, kterou vyhlašujeme společně s @DianaBiotech, se už blíží! 📅 Přijďte 16. dubna na @muni_cz nebo se připojte online a oslavte s námi úspěchy českých vědců působících v zahraničí! Letos se kromě slavnostního předání můžete těšit i na přednášky a diskuzi tří výjimečných mladých vědců 👇 🧬 @biomonika zkoumá nejkomplexnější a nejrepetitivnější části lidského genomu a jejich dědičnost napříč generacemi. ⚖️ @DrapalJakub se věnuje roli podmíněného trestu odnětí svobody v českém právním systému – proč je stále tak dominantní? 🤖 @stanislavfort se snaží pochopit principy lidské inteligence a na jejich základě stavět bezpečné systémy umělé inteligence – podílel se např. na vývoji Claude (@AnthropicAI) nebo Gemini (@GoogleDeepMind). ‼️ Registrace na slavnostní předávání je nutná pro osobní i online účast, proto prosíme o včasnou registraci tady 👉 docs.google.com/forms/d/e/1F…‼️ Moc se na vás těšíme! 💙
4
146
DB | When unreliable suppliers fail. The story behind our new custom oligonucleotide synthesis in @vedavyzkum_cz "The purity of the supply products was not always optimal, and delivery times often did not meet our needs. Our development required extremely complex oligos—branched, modified, with different dyes or other non-standard modifications. We quickly realized that unless we started producing them ourselves, no one would supply them to us" That's how the article in @vedavyzkum_cz about our oligonucleotide synthesis starts. And that is also one of the first things our Head of Chemistry, Jiri Schimer said during the interview. And what started as an internal necessity has grown into a full-fledged service, offering custom oligonucleotide synthesis for wide range of customers! And what you can get? ✅ TaqMan™ probes, siRNA, LNA-modified oligos ✅ Custom labels with dyes, metal complexes, and advanced modifications ✅ Molecular beacons for cutting-edge diagnostics & research and many more! ⚡DB Oligonucleotide Calculator: The calculator we created is currently the most flexible and user-friendly on the oligonucleotide market. Just enter your desired sequence and modifications and you will get the price and the request immediately. 💡 A customer-first approach We would be more than happy to help you with initial design or project consultation. 📖 Read the full article here: CZ: vedavyzkum.cz/inovace-a-tran… EN: dianabiotech.com/company/art… Kudos to: @MasinovaTereza and Kamil Krč
1
4
147
👩‍🔬 February 11 | International Day of Women and Girls in Science Only 30% of scientists in the Czech Republic are women—one of the lowest rates in the EU. Fortunately, initiatives for gender equality in science have been gaining momentum. However, our company stands out—we’ve consistently had around 60% women in various roles over the past few years. So let's meet them!
1
116
🔬 Lucia, Drug Discovery: We’re expanding our DIANA Kinase panel, now covering ~150 kinases, with the goal of profiling the entire kinome. In 2024, we introduced our screening services at multiple conferences, receiving great feedback. With our newly established CRO, we provide fast, precise, and cost-effective small-molecule profiling, for wide range of clients.
1
64
🧬 Klara, Monoclonal Antibodies Development: My work spans the entire antibody development process—from designing immunization strategies to cloning antibody chains into plasmids. I also manage data analysis and databases, which is increasingly crucial as we take on more commercial projects and develop new antibody clones.
65